Dr. Nancy Saad is a valued member of the research team at the Ohio State University Wexner Medical Center, holding both a Ph.D. in Cardiac Physiology and Cell Biology and an M.S. in Pharmaceutical Sciences. Since 2019, her role as a Research Scientist has centered on the study of the contractile and kinetic properties of the failing human myocardium, as well as the investigation of how various diseases and pharmacological agents affect these cardiac properties. Additionally, she is interested in studying the differences in contractile protein phosphorylation and expression at various ages in human myocardial tissue. Her research efforts also include investigating the impact of dysfunctional skeletal muscle relaxation on muscular dystrophy disease in mice. She is a member of several scientific societies, including the American Heart Association, Biophysical Society, Heart Failure Society of America, and Sigma Xi, the Scientific Research Honor Society. Her ultimate research objectives are to elucidate the molecular and cellular mechanisms that underlie human heart disease, particularly heart failure, and to develop new preventive and therapeutic measures against this global health issue, which is the leading cause of death in the United States and worldwide.